$40.8MSeries B, 7 August 2025
Funds will advance CRISPR therapies for cystic fibrosis airway infections and SNIPR001 for blood cancers.
- Amount
- $40.8M
- Stage
- Series B
- Announced
- 7 August 2025
- Lead
- Cystic Fibrosis Foundation
- Other investors
- SPRIN-D, Lundbeckfonden BioCapital, North-East Family Office, Wellington Partners
- Use of funds
- Funds will advance CRISPR therapies for cystic fibrosis airway infections and SNIPR001 for blood cancers.
- Checked
- Amount and date matched across 2 press sources
- Sources
- SNIPR Biome raises EUR 35M Series B (Tech.eu amount EUR-normalized) siliconcanals.com
SNIPR Biome raises EUR 35M Series B (Tech.eu amount EUR-normalized) funding.tech.eu